ImmunityBio: Jefferies raises target price to $14 from $12
IBRX•Jefferies raised its target price for ImmunityBio to $14 from $12.
Related News
Japan's Nikkei plunges as tech stocks are hammered by AI and rate hike worries
EWJ•
Viant Technology CFO Larry Madden reports sale of common shares worth $272,059.696
DSP•
RBC raises Quaker Houghton's target price to $202 from $198
KWR•
Market picks CoreWeave as AI rout deepens
CRWV•
Oil prices fall as investors weigh supply outlook, Middle East tensions
USO•